Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma
- PMID: 1844911
Tn antigen and UDP-Gal:GalNAc alpha-R beta 1-3Galactosyltransferase expression in human breast carcinoma
Abstract
The serine/threonine O-linked carbohydrates GalNAc alpha and Gal beta 1-3GalNAc alpha, referred to as Tn and T antigens, respectively, appear to be more prevalent in some human carcinomas than in surrounding tissues. Tn/T antigens may represent incomplete synthesis of O-linked oligosaccharides, due to decreased activity of specific glycosyltransferases, or alternatively, increased glycosidases activity in tumors which may expose these internal O-linked oligosaccharide sequences. To explore these possibilities, we measured UDP-Gal:GalNAc alpha-R beta 1-3 galactosyltransferase (beta 3Gal-T) and Gal beta 1-3GalNAc alpha-R beta 1-3 galactosidase in a series of human breast tumors. In addition, glycoproteins extracted from the tumors were separated by SDS-PAGE and stained with the lectins HPA (GalNAc alpha-R reactive) and PNA (Gal beta-3GalNAc alpha-R reactive). The relative levels of HPA- to PNA-reactive glycoproteins in the carcinomas correlated inversely with beta 3Gal-T activities. The results suggest that Tn antigen expression in human breast carcinoma is due in part to low beta 3Gal-T activity, a situation similar to that observed previously in haematopoietic cells of individuals with a condition called Tn syndrome.
Similar articles
-
T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability.Eur J Immunol. 1992 Jul;22(7):1835-42. doi: 10.1002/eji.1830220724. Eur J Immunol. 1992. PMID: 1378020
-
Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome.J Clin Invest. 1993 May;91(5):2103-10. doi: 10.1172/JCI116434. J Clin Invest. 1993. PMID: 7683697 Free PMC article.
-
Lectinochemical studies on the glyco-recognition factors of a Tn (GalNAcalpha1-->Ser/Thr) specific lectin isolated from the seeds of Salvia sclarea.J Biomed Sci. 2005;12(1):167-84. doi: 10.1007/s11373-004-8180-x. J Biomed Sci. 2005. PMID: 15864748
-
Differential binding properties of Gal/GalNAc specific lectins available for characterization of glycoreceptors.Indian J Biochem Biophys. 1997 Feb-Apr;34(1-2):61-71. Indian J Biochem Biophys. 1997. PMID: 9343930 Review.
-
Differential binding properties of Ga1NAc and/or Ga1 specific lectins.Adv Exp Med Biol. 1988;228:205-63. Adv Exp Med Biol. 1988. PMID: 3051916 Review.
Cited by
-
Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker.Mol Cancer. 2003 Nov 5;2:38. doi: 10.1186/1476-4598-2-38. Mol Cancer. 2003. PMID: 14613581 Free PMC article.
-
Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes.Int J Surg Oncol. 2012;2012:861257. doi: 10.1155/2012/861257. Epub 2012 Dec 24. Int J Surg Oncol. 2012. PMID: 23320158 Free PMC article.
-
Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancer.Proteomics. 2016 Dec;16(24):3062-3072. doi: 10.1002/pmic.201500553. Epub 2016 May 11. Proteomics. 2016. PMID: 27005968 Free PMC article. Review.
-
Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant.Cancer Immunol Immunother. 1993;36(4):215-22. doi: 10.1007/BF01740902. Cancer Immunol Immunother. 1993. PMID: 8439984 Free PMC article. Clinical Trial.
-
Glycosylations versus conformational preferences of cancer associated mucin core.Glycoconj J. 2000 Dec;17(12):835-48. doi: 10.1023/a:1010909011496. Glycoconj J. 2000. PMID: 11511808
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical